• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconFDA

FDA

Page 9 of 35
HealthPowerful new obesity drug from Eli Lilly expected to be one of best selling drugs of all time, with sales over $50bn a year
By Jonel Aleccia and The Associated PressApril 27, 2023
HealthFDA signals the growing recognition of the gut in health by approving the first fecal transplant pill
By Matthew Perrone and The Associated PressApril 26, 2023
FDA
HealthFirst-of-its-kind drug for rare form of Lou Gehrig’s disease gets FDA approval
By Matthew Perrone and The Associated PressApril 25, 2023
Makena
HealthFDA orders immediate withdrawal of only drug approved for preterm birth prevention
By Matthew Perrone and The Associated PressApril 6, 2023
a picture of a large meatball
LifestyleScientists have created a meatball made from a genetically-engineered mammoth—but no one is allowed to eat it
By Prarthana PrakashMarch 30, 2023
HealthUnproven birth drug that symbolized the FDA’s struggle to pull drugs from the market is finally withdrawn
By Matthew Perrone and The Associated PressMarch 8, 2023
TechNo, Elon Musk can’t put chips into people’s brains: Regulators rejected Neuralink’s device due to safety risks, report says
By Will DanielMarch 2, 2023
HealthHow officials cracked case of eyedrops that blinded people: ‘A public health victory’
By Mike Stobbe and The Associated PressFebruary 28, 2023
HealthThe FDA is using YouTube and Twitter to try and tackle ‘a leading cause of death in America’: Online misinformation
By Matthew Perrone and The Associated PressFebruary 21, 2023
HealthFDA committee plots future of COVID vaccines, with Omicron formula and potentially annual booster shots
By Erin PraterJanuary 26, 2023
Joe Biden
HealthThe FDA just finalized a Biden rule change to make abortion pills much more widely available at pharmacies nationwide
By Matthew Perrone and The Associated PressJanuary 4, 2023
FDA
HealthThe FDA’s speedy approval of experimental new drugs came to a screeching halt this year
By Matthew Perrone and The Associated PressDecember 7, 2022
Man with IV
HealthIf you have hemophilia, you can now get a one-time gene therapy for $3.5 million
By Matthew Perrone and The Associated PressNovember 23, 2022
Birth control pills
HealthU.S. considering its very first over-the-counter birth control pill: Here’s who’s on board and who isn’t
By Sophie MellorOctober 4, 2022
Hearing aids
HealthFDA approves over-the-counter hearing aids in the U.S.
By Matthew Perrone and The Associated PressAugust 16, 2022
1...
  • 7
  • 8
  • 9
  • 10
  • 11
...35
Most Popular
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strongAn image of a popular article
By Fortune EditorsMarch 24, 2026
Commentary
The Treasury just declared the U.S. insolvent. The media missed itAn image of a popular article
By Fortune EditorsMarch 23, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers — ‘or you’re neurodivergent’An image of a popular article
By Fortune EditorsMarch 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.